ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Clinical trials for ENDOMETRIAL UNDIFFERENTIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL UNDIFFERENTIATED CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive uterine cancer: targeted combo shows promise in phase 3 trial
Disease control Recruiting nowThis study tests whether adding two targeted drugs (trastuzumab and pertuzumab) to standard chemotherapy can shrink tumors and stop HER2-positive endometrial cancer from coming back. About 360 people with stage I to IV cancer will receive either chemo alone or chemo plus the targ…
Matched conditions: ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Immunotherapy duo shows promise against tough uterine cancer
Disease control Recruiting nowThis study is for people with a type of recurrent endometrial cancer that has a specific DNA repair problem (called dMMR). It compares a combination of two immunotherapy drugs (nivolumab and ipilimumab) against one drug alone (nivolumab) to see which shrinks tumors better. About …
Matched conditions: ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:56 UTC